Supplements for Critically Ill Patients

What the Research Shows

Clinical research on supplements for critically ill patients shows mixed results, with few interventions demonstrating a clear, universal benefit. High-dose antioxidants and certain vitamins have been studied extensively, but evidence remains conflicting; some trials suggest potential benefits in specific contexts, while others show no impact or potential harm. Consequently, most general nutritional supplements currently hold weak to moderate evidence for improving overall survival rates in intensive care settings. Specific evidence for immune-modulating supplements is limited. For instance, there is insufficient evidence to support the use of colostrum in critically ill populations. While some studies explore the use of omega-3 fatty acids or glutamine, the strength of evidence varies by patient condition, and consistent positive outcomes across diverse critical care scenarios have not been established. The current body of research is limited by small sample sizes and a lack of standardized protocols, making it difficult to draw definitive conclusions about the efficacy of these supplements.

AI-generated overview based on research evidence. Not medical advice.

This page is generated from AI-analyzed evidence summaries. Evidence strength ratings are based on the quality and quantity of available research, not guaranteed effectiveness. Always consult a healthcare provider before using supplements for any health condition.

See our Editorial Policy for methodology and Medical Disclaimer.